ArticleEpidemiology and health2015
Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean.
Article in Epidemiology and health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 12 citations in OpenAlex.
- What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea.Cancer medicine · 2024Article
- Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999-2020.Investigative and clinical urology · 2024Article
- Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.Cancer medicine · 2021Article
- A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up.Investigative and clinical urology · 2021Article
- Cancer Incidence by Occupation in Korea: Longitudinal Analysis of a Nationwide Cohort.Safety and health at work · 2020Article
- Potential Epigenetic Biomarkers for Prostate Cancer Screening.International neurourology journal · 2018Article
- Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe prostate specific antigen test is widely used as the main method of screening prostate cancer in Korea. Additionally, the use of ultrasound sonography may lead to overdiagnosis of kidney cancer as well as thyroid cancer. This study aimed to highlight epidemiological evidences regarding overdiagnosis of prostate and kidney cancers in Korean.
methodsThe annual trends of national incidence and mortality of prostate and kidney cancers provided by the Korean Statistical Information Service were evaluated.
resultsThe rate of increase in the incidence of prostate and kidney cancer was 6 and 5 times higher than that of mortality between 2000 and 2011, respectively. Additionally, the age group showing the highest incidence in prostate cancer shifted from 85 years and older to 75-79 years.
conclusionsThis evidence suggests that prostate and kidney cancers are overdiagnosed in Korea. Further research in this area, using national cancer registry databases, should be encouraged to prevent overdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.